Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells

Oncotarget
Vincent Kam Wai WongLiang Liu

Abstract

Energy metabolism in cancer cells is often increased to meet their higher proliferative rate and biosynthesis demands. Suppressing cancer cell metabolism using agents like metformin has become an attractive strategy for treating cancer patients. We showed that a novel ginsenoside derivative, Rh2E2, is as effective as aspirin in preventing the development of AOM/DSS-induced colorectal cancer and suppresses tumor growth and metastasis in a LLC-1 xenograft. A sub-chronic and acute toxicity LD50 test of Rh2E2 showed no harmful reactions at the maximum oral dosage of 5000 mg/kg body weight in mice. Proteomic profiling revealed that Rh2E2 specifically inhibited ATP production in cancer cells via down-regulation of metabolic enzymes involving glycolysis, fatty acid β-oxidation and the tricarboxylic acid cycle, leading to specific cytotoxicity and S-phase cell cycle arrest in cancer cells. Those findings suggest that Rh2E2 possesses a novel and safe anti-metabolic agent for cancer patients by specific reduction of energy-based metabolism in cancer cells.

References

Jun 18, 1999·Diabetes Care·M StangD Butler-Jones
Jan 7, 2000·Biochemical and Biophysical Research Communications·D NieK V Honn
Aug 26, 2000·Chemical & Pharmaceutical Bulletin·R KasaiK Yamasaki
Sep 26, 2001·The Journal of Biological Chemistry·S BurmaD J Chen
Jul 3, 2002·Annals of Internal Medicine·Dmitri KirpichnikovJames R Sowers
Jan 17, 2003·The Biochemical Journal·Kui XuLyubomir T Vassilev
Mar 4, 2003·Nature Reviews. Cancer·Yosef Shiloh
Aug 28, 2003·Integrative Cancer Therapies·Yuan S ChangKeith I Block
Sep 7, 2004·The International Journal of Developmental Biology·Lara D M Derycke, Marc E Bracke
Nov 2, 2004·Nature Reviews. Cancer·Robert A Gatenby, Robert J Gillies
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vincent K W WongBen C B Ko
Feb 16, 2006·American Journal of Physiology. Endocrinology and Metabolism·Cheryl A CollierDavid J Dyck
Jun 30, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Baolin Zhang
May 16, 2007·The Journal of Cell Biology·Satoru YamasakiToshio Hirano
Aug 29, 2007·The Journal of Cell Biology·Yuval YungRichard K Assoian
Sep 4, 2007·The Lancet Oncology·Ashley M GrovesPeter J Ell
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Feb 10, 2009·Current Opinion in Genetics & Development·Xuemei TongCraig B Thompson
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Mar 27, 2009·Carcinogenesis·Daniel A TennantEyal Gottlieb
May 12, 2009·Bioorganic & Medicinal Chemistry Letters·Jie LiuRyuichiro Kondo
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Aug 12, 2009·Development·Yemima Budirahardja, Pierre Gönczy
Dec 30, 2009·The Journal of Clinical Investigation·Ismael SamudioMichael Andreeff
Mar 20, 2010·Nature Reviews. Cancer·Daniel A TennantEyal Gottlieb
Apr 20, 2010·Trends in Cell Biology·Zhaohui Feng, Arnold J Levine
May 6, 2010·Molecular Cancer Therapeutics·Issam Ben SahraFrédéric Bost
Jan 26, 2011·The FEBS Journal·Michela CapelloFrancesco Novelli
Sep 1, 2011·Nature Reviews. Drug Discovery·Matthew G Vander Heiden
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Yves St-PierreAndree-Anne Grosset
Aug 11, 2012·Briefings in Bioinformatics·Elaine L LeungLiang Liu
Nov 3, 2012·Journal of Biomedicine & Biotechnology·Angels Díaz-RamosRoser López-Alemany
Mar 15, 2013·Nature Reviews. Molecular Cell Biology·Yosef Shiloh, Yael Ziv
Apr 24, 2013·Current Pharmaceutical Design·Anna-Maria StockFrank Entschladen

❮ Previous
Next ❯

Methods Mentioned

BETA
column chromatography
xenograft
electrophoresis
proteomic profiling
Transfection
Assay

Software Mentioned

MASCOT
MASCOT Server
Modfit
Bruker Compass Data Analysis
image J
DeCyder differential
FlexAnalysis
GraphPad
Prism
GraphPadPrism

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.